Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

APR 03, 2013 - Boston Globe

A Must Read - Share

Pfizer inks deal with BIND Therapeutics, a Cambridge nanotechnology drugmaker

BIND Therapeutics said Wednesday that Pfizer Inc. has agreed to pay it $160 million per drug as part of a collaboration to develop targeted medicines using nanotechnology which use particles measured in billionths of a meter. BIND is developing an experimental group of targeted, programmable medicines called Accurins to treat cancer, heart disease, and inflammatory disorders. The privately held company’s technology comes from two laboratories that specialize in nanotechnology at Harvard Medical School and the Massachusetts Institute of Technology. Pfizer will make initial payments of roughly ... Read More

Tags: Pfizer inks deal with BIND Therapeutics, a Cambridge nanotechnology drugmaker,  Pfizer Latest News